| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/02/2014 | US20140005249 Nkx2.2 inhibitors as drugs |
| 01/02/2014 | US20140005113 Treatment of disorders with altered vascular barrier function |
| 01/02/2014 | US20140005093 Pectate Lyase Variants |
| 01/02/2014 | US20140005077 Methods for Identifying and Isolating Cells Expressing a Polypeptide |
| 01/02/2014 | US20140005076 Methods for Identifying and Isolating Cells Expressing a Polypeptide |
| 01/02/2014 | US20140005062 Method to Assess Patterns of Molecular Expression |
| 01/02/2014 | US20140005057 Protein variant generation by region shuffling |
| 01/02/2014 | US20140004608 Meganuclease recombination system |
| 01/02/2014 | US20140004607 Targeted alteration of dna |
| 01/02/2014 | US20140004604 Ets2 and mesp1 generate cardiac progenitors from fibroblasts |
| 01/02/2014 | US20140004603 Urocortin-iii and uses thereof |
| 01/02/2014 | US20140004602 DinQ-sRNA TYPE I TOXIN-ANTITOXIN SYSTEM FOR PLASMID MAINTENANCE |
| 01/02/2014 | US20140004598 Biological methods for preparing adipic acid |
| 01/02/2014 | US20140004587 Egvii endoglucanase and nucleic acids encoding the same |
| 01/02/2014 | US20140004580 Modified photosynthetic microorganisms for producing lipids |
| 01/02/2014 | US20140004567 Recombinational cloning using nucleic acids having recombination sites |
| 01/02/2014 | US20140004564 Compositions and methods for improved protein production |
| 01/02/2014 | US20140004196 Polyamide-amine dendrimer or derivative thereof-math1 gene nano particle and use thereof in treatment of hearing loss |
| 01/02/2014 | US20140004156 Biological inhibitors of ror1 capable of inducing cell death |
| 01/02/2014 | US20140004154 Pharmaceutical Composition Consisting Of RNA Having Alkali Metal As Counter Ion And Formulated With Dications |
| 01/02/2014 | US20140004143 Adeno-associated virus (aav) serotype 8 sequences, vectors containing same, and uses therefor |
| 01/02/2014 | US20140004134 Nf-kb signaling pathway-manipulated dendritic cells |
| 01/02/2014 | US20140004107 St2 antigen binding proteins |
| 01/02/2014 | US20140004100 Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response |
| 01/02/2014 | US20140004095 Albumin fusion proteins |
| 01/02/2014 | US20140004089 Chimeric glycoproteins and pseudotyped lentiviral vectors |
| 01/02/2014 | US20140004088 Identification and use of target genes for control of plant parasitic nematodes |
| 01/02/2014 | US20140004037 Stabilization of the anti-cd20 antibody rituximab |
| 01/02/2014 | DE102012012523A1 Reinigung von Nukleinsäuren Purification of nucleic acids |
| 01/01/2014 | EP2679687A2 Fatty acid blends and uses therefor |
| 01/01/2014 | EP2679686A1 Nucleic acid molecule encoding xylose isomerase and xylose isomerase encoded thereof |
| 01/01/2014 | EP2679685A1 Methods and organisms for the growth-coupled production of 1,4-butanediol |
| 01/01/2014 | EP2679684A1 Methods and organisms for the growth-coupled production of 1,4-butanediol |
| 01/01/2014 | EP2679683A2 Novel varicella-zoster virus strains, and chicken pox and herpes zoster virus vaccine using same |
| 01/01/2014 | EP2679682A1 Alkaline phosphatase |
| 01/01/2014 | EP2679681A1 Fc riib-specific fc antibody |
| 01/01/2014 | EP2679680A1 L-cysteine-producing bacterium and method for producing l-cysteine |
| 01/01/2014 | EP2679671A1 A bank of stem cells for producing cells for transplantation having HLA antigens matching those of transplant recipients, and methods for making and using such a stem cell bank |
| 01/01/2014 | EP2679668A1 Transformant for producing lactic acid having high optical purity, and method for producing lactic acid using same |
| 01/01/2014 | EP2679667A1 Xylose-fermenting microorganism |
| 01/01/2014 | EP2679237A1 Myostatin inhibition for enhancing muscle and/or improving muscle function |
| 01/01/2014 | EP2679089A1 Line design |
| 01/01/2014 | EP2678450A2 Recurrent spop mutations in prostate cancer |
| 01/01/2014 | EP2678449A2 Methods and systems for haplotype determination |
| 01/01/2014 | EP2678435A1 Aav -vectors for use in gene therapy of choroideremia |
| 01/01/2014 | EP2678434A2 Genetically modified animals and methods for making the same |
| 01/01/2014 | EP2678433A1 Delivery of proteins using adeno-associated virus (aav) vectors |
| 01/01/2014 | EP2678432A2 Recombinant microorganisms and uses therefor |
| 01/01/2014 | EP2678431A1 Oligonucleotide inhibitors with chimeric backbone and 2-amino-2'-deoxyadenosine |
| 01/01/2014 | EP2678430A1 Use of template switching for dna synthesis |
| 01/01/2014 | EP2678429A2 Microfluidic device-based nucleic acid purification method |
| 01/01/2014 | EP2678428A1 Plant protease |
| 01/01/2014 | EP2678426A1 Proteins for biocontrol of plant pathogenic fungi |
| 01/01/2014 | EP2678421A1 Processes and recombinant microorganisms for the production of cadaverine |
| 01/01/2014 | EP2678352A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 01/01/2014 | EP2678351A1 Rapid selection method for hiv gp-120 variants |
| 01/01/2014 | EP2678040A1 A system for cargo delivery into the cells |
| 01/01/2014 | EP2677859A2 Methods of weed control involving aad-1 plants, and re-plant and/or pre-emergence herbicide applications |
| 01/01/2014 | EP2677858A2 Canola germplasm exhibiting seed compositional attributes that deliver enhanced canola meal nutritional value having omega-9 traits |
| 01/01/2014 | EP1682573B1 The use of eukaryotic genes affecting cell cycle control or cell cycle progression for diagnosis and treatment of proliferattive diseases |
| 01/01/2014 | CN103492865A Method for determining polynucleotide base sequence and device for determining polynucleotide base sequence |
| 01/01/2014 | CN103492588A Methods and systems for haplotype determination |
| 01/01/2014 | CN103492587A Polymerization of nucleic acids using activation by polyphosphorolysis (APP) reactions |
| 01/01/2014 | CN103492578A Methods for genomic modification |
| 01/01/2014 | CN103492577A Expression vector for animal cells |
| 01/01/2014 | CN103492576A Genetically modified pigs for xenotransplantation of vascularized xenografts and derivatives thereof |
| 01/01/2014 | CN103492575A Nav1.7 knockout mice and uses thereof |
| 01/01/2014 | CN103492574A Delivery of proteins using adeno-associated virus (aav) vectors |
| 01/01/2014 | CN103492573A Plants having enhanced yield-related traits and producing methods thereof |
| 01/01/2014 | CN103492572A Compositions and methods for treating lung disease and injury |
| 01/01/2014 | CN103492571A Pharmaceutical composition containing L-DNA |
| 01/01/2014 | CN103492569A Base modified oligonucleotides |
| 01/01/2014 | CN103492568A Galactose cluster-pharmacokinetic modulator targeting moiety for siRNA |
| 01/01/2014 | CN103492566A Composition for predicting sensitivity to trastuzumab therapy in breast cancer patients and method using same |
| 01/01/2014 | CN103492565A FcgRIIb-specific Fc antibody |
| 01/01/2014 | CN103492564A Light-activated chimeric opsins and methods of using the same |
| 01/01/2014 | CN103492562A Methods and materials for enhancing functional protein expression in bacteria |
| 01/01/2014 | CN103492561A Cellulase compositions and methods of using the same for improved conversion of lignocellulosic biomass into fermentable sugars |
| 01/01/2014 | CN103492553A Processes and recombinant microorganisms for the production of cadaverine |
| 01/01/2014 | CN103492551A Microorganism for c4-dicarboxylic acid production |
| 01/01/2014 | CN103492550A Method for lysing cells |
| 01/01/2014 | CN103492419A Binding molecules capable of neutralizing the rabies virus, and uses thereof |
| 01/01/2014 | CN103492418A Antibodies against kidney associated antigen 1 and antigen binding fragments thereof |
| 01/01/2014 | CN103492417A Tumor specific antibodies and uses therefor |
| 01/01/2014 | CN103492411A Mutant interleukin-2 polypeptides |
| 01/01/2014 | CN103492410A Bluetongue virus recombinant vaccines and uses thereof |
| 01/01/2014 | CN103491979A Malaria vaccines based on pre-erythrocytic antigens from p. falciparum |
| 01/01/2014 | CN103491767A Canola germplasm exhibiting seed compositional attributes that deliver enhanced canola meal nutritional value having omega-9 traits |
| 01/01/2014 | CN103484942A Thermophilic streptomyces hygroscopicus cDNA library construction, and expression and expression methods of two greenhouse farmer's lungpathopoiesia antigen polypeptides |
| 01/01/2014 | CN103484572A Kit for detecting swine influenza viruses and application thereof |
| 01/01/2014 | CN103484571A LAMP (loop-mediated isothermal amplification) detection primer group, detection kit and detection method for infectious hypodermal and hematopoietic necrosis virus |
| 01/01/2014 | CN103484566A Primer, kit and method for conducting genetic typing on hantavirus by means of PCR direct sequencing method |
| 01/01/2014 | CN103484562A IL-17A gene real-time fluorescent PCR (polymerase chain reaction) detection primers and kit |
| 01/01/2014 | CN103484559A Primer and kit for real-time fluorescence PCR (polymerase chain reaction) detection of APRIL (a proliferation inducing ligand) gene |
| 01/01/2014 | CN103484557A Plasmid standard molecule applicable to real-time fluorescence quantification PCR (Polymerase Chain Reaction) detection of enterobacter sakazakii |
| 01/01/2014 | CN103484556A Primer and method for detecting molecular marker of rice aroma allele |
| 01/01/2014 | CN103484555A Method for identifying authenticity of sweet potato variety by using inter-simple sequence repeat (ISSR) molecular marker method |
| 01/01/2014 | CN103484554A Primer and method for detecting transgenic maize strain MIR162 |
| 01/01/2014 | CN103484550A MicroRNA biological markers for early lung cancer diagnosis and application thereof |
| 01/01/2014 | CN103484546A Fourteen-food-borne pathogenic bacterium multiplex PCR detection primer set and kit |